linkedin
 
You Are On
Equity
Equity Analysis
News Analysis
Corporate Action
Corporate Info
Derivatives
Other Market
Research
 
 Shareholdings  
Bafna Pharmaceuticals Ltd.
 
BSE Code 532989
ISIN Demat INE878I01022
Book Value 40.64
NSE Code BAFNAPH
Dividend Yield % 0.00
Market Cap 4185.99
P/E 37.71
EPS 4.69
Face Value 10  
Description ( As On March 2026 )No. of ShareHoldersNo. of Shares% of SharesDemat
Promoter          
  Indian Promoter  7  17742251  75  17742251  
  Foreign Promoter          
  Total Promoter  7  17742251  75  17742251  
          
Non Promoter          
 Institutions          
  Mutual Funds / UTI          
  FI/Bank/Insurance          
  Govt          
  FII          
  Other  3  2209803  9.34  2209803  
  Total Institutions  3  2209803  9.34  2209803  
 Non-Institution          
  Bodies Corporate  48  585656  2.48  585156  
  Individuals          
  NRIs/OCBs  65  126812  0.54  126812  
  Others  6805  2991813  12.64  2985273  
  Total Non-Institution  6918  3704281  15.66  3697241  
Total Non Promoter  6921  5914084  25  5907044  
          
  Depository Receipts          
          
Grand Total  6928  23656335  100  23649295  
 
RMS | Policies & Procedures| PMLA | Disclaimer | Privacy Policy | Web Mail | Relationship | Investor Grievance
Career | Contact Us| KYC| PMS Risk Disclosure | Key Managerial Person | Basic Details | Process of Opening an Account | Process of Filing Complaint
Links to MCX | NCDEX |FMC | NCDEX CMID NCDEX-CO-04-00129 | MCX 10550 | FMC MCX: MCX/TCM/CORP/0008| FMC NCDEX : NCDEX/TCM/CORP/0274    
NSE: INB230914036 |NSE F & O INF230914036 |BSE: INB010914032 |BSE F & O: INF010914032 | CDSL: IN-DP-CDSL-335-2006 | OTC: INB200914032
Related Sites: Bombay Stock Exchange (BSE), Investor Protection, National Stock Exchange (NSE), Securities & Exchange Board of India (SEBI)
© Padmakshi 2009. All Rights Reserved. Designed || Developed & Content Powered By Accord Fintech Pvt. Ltd.